CureApp
Latest round
- Series F
Last raised
- Mar 2021
Total raised
- $54M
Investors
- 20
About CureApp
CureApp, Inc., founded in 2014 and headquartered in Tokyo, Japan, is focused on developing digital therapeutics that offer alternative treatment options.0 billion.CureApp specializes in developing innovative digital therapeutics, primarily through their flagship product, the treatment app, which leverages medical evidence to address conditions inadequately managed by traditional pharmaceuticals and hardware medical devices. These apps aim to facilitate new treatment interventions during non-clinical hours, such as at home or while out, enabling patients to receive personalized support through the app interface. The company targets various health conditions, including nicotine dependence and non-alcoholic steatohepatitis (NASH), with its products being utilized in both clinical settings and corporate health initiatives. CureApp's solutions are designed to enhance health outcomes by promoting behavioral change and encouraging adherence to treatment protocols among users.CureApp's revenue model is primarily based on partnerships and B2B transactions, particularly with healthcare institutions and corporate wellness programs. Their apps are structured to provide subscription-based access for users, facilitating ongoing treatment and support. For instance, their complete online smoking cessation program, "ascure," is part of various health initiatives in Japan, indicating a strategic approach to integrating their solutions into broader health systems. While specific pricing plans are not disclosed, the company’s offerings are built around tailored solutions for healthcare providers, demonstrating their commitment to delivering value to both patients and institutions.0 billion, CureApp plans to invest these funds into the development of new digital therapeutics products and services. The company is also looking to expand its market presence beyond Japan, targeting new geographic regions to reach more patients in need of innovative therapeutic options. Specific expansion timelines and new product launch dates have yet to be disclosed, but the company is actively working towards enhancing its offerings to further support patient care.
Who invested in CureApp
20 investors across 6 rounds
See all investors in CureApp
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CureApp
Who invested in CureApp?
CureApp has 20 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CureApp raised?
CureApp has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did CureApp last raise money?
CureApp's most recent round on record is a Series F, in Mar 2021.
What does CureApp do?
CureApp is a healthcare it company.
Where is CureApp headquartered?
CureApp is headquartered in Tokyo, Japan.
Which VCs invest in companies like CureApp?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare it companies at CureApp's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series F
Raising like CureApp? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.